Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kirschner

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Klinische Wochenschrift|January 1, 1986
Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascitesG Brabant, H Jüppner, M Kirschner, et al.
Der Unfallchirurg|March 10, 2004
[Diagnosis and therapy of acute complaints after "whiplash injury" in Germany. Results of a representative survey at surgical and trauma departments in Germany]M Schnabel, M Weber, T Vassiliou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2008
The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cellsKarin M Kirschner, Patricia Hagen, Christiane S Hussels, et al.
Blood|February 10, 2006
Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin geneChristof Dame, Karin M Kirschner, Katharina V Bartz, et al.
The Journal of Cell Biology|October 1, 1991
Microtubule behavior during guidance of pioneer neuron growth cones in situJ H Sabry, T P O'Connor, L Evans, et al.
Der Nephrologe|May 1, 2020
[Side effects of novel cancer immunotherapies]G S Braun, M Kirschner, A Rübben, et al.
The Journal of Emergency Medicine|October 15, 2018
Do Orthostatic Vital Signs Have Utility in the Evaluation of Syncope?Jason T Schaffer, Samuel M Keim, Benton R Hunter, et al.
Development (Cambridge, England)|February 18, 2005
A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory systemNicole Wagner, Kay-Dietrich Wagner, Annette Hammes, et al.
Journal of Equine Veterinary Science|May 29, 2019
Evaluation of a Proprietary Slow-Release Oxytocin Formulation on Corpus Luteum Function in MaresBrendan A Sarnecky, Dirk K Vanderwall, Holly M Mason, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 1, 1997
[Regression of Yoshida sarcoma during normoxia and hypoxia after fractionated irradiation]V Strnad, F Kamprad, J Jahns, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Klinische Wochenschrift|January 1, 1986
Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascitesG Brabant, H Jüppner, M Kirschner, et al.
Der Unfallchirurg|March 10, 2004
[Diagnosis and therapy of acute complaints after "whiplash injury" in Germany. Results of a representative survey at surgical and trauma departments in Germany]M Schnabel, M Weber, T Vassiliou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2008
The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cellsKarin M Kirschner, Patricia Hagen, Christiane S Hussels, et al.
Blood|February 10, 2006
Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin geneChristof Dame, Karin M Kirschner, Katharina V Bartz, et al.
The Journal of Cell Biology|October 1, 1991
Microtubule behavior during guidance of pioneer neuron growth cones in situJ H Sabry, T P O'Connor, L Evans, et al.
Der Nephrologe|May 1, 2020
[Side effects of novel cancer immunotherapies]G S Braun, M Kirschner, A Rübben, et al.
The Journal of Emergency Medicine|October 15, 2018
Do Orthostatic Vital Signs Have Utility in the Evaluation of Syncope?Jason T Schaffer, Samuel M Keim, Benton R Hunter, et al.
Development (Cambridge, England)|February 18, 2005
A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory systemNicole Wagner, Kay-Dietrich Wagner, Annette Hammes, et al.
Journal of Equine Veterinary Science|May 29, 2019
Evaluation of a Proprietary Slow-Release Oxytocin Formulation on Corpus Luteum Function in MaresBrendan A Sarnecky, Dirk K Vanderwall, Holly M Mason, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 1, 1997
[Regression of Yoshida sarcoma during normoxia and hypoxia after fractionated irradiation]V Strnad, F Kamprad, J Jahns, et al.
Pageof 17